PHARMACYTE BIOTECH, INC. Total Long-Term Debt
PHARMACYTE BIOTECH, INC. (PMCB) had Total Long-Term Debt of $247.93 thousand as of 2012-01-31, per its 10-Q filed 2012-03-21.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2012-03-21
- 2012-01-31: Long-term Debt $247.93K.
- 2011-04-30: Long-term Debt $0.00.
| Period end | Long-term Debt |
|---|---|
| 2012-01-31 | $247.93K 10-Q · filed 2012-03-21 |
| 2011-04-30 | $0.00 10-Q · filed 2012-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |